Full-Time

Principal Investigator

Posted on 9/26/2024

Celerion

Celerion

1,001-5,000 employees

Clinical research organization for drug development

Biotechnology
Healthcare

Mid, Senior

Tempe, AZ, USA

Position requires onsite presence in Tempe, AZ.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • MD or DO degree and current state license.
  • Basic Life Support and Advanced Cardiac Life Support certification
  • Successful completion of an ACGME residency program in family medicine, internal medicine, or emergency medicine.
  • Hold a DEA certificate for schedule II medications
  • 3-5 years of medical/clinical experience preferred
  • Clinical research experience preferred
  • Bilingual English/Spanish preferred in AZ
  • Able to work a flexible schedule
Responsibilities
  • Review protocol and Investigator Brochure for subject safety, scientific, and operational feasibility of study. Provide input to sponsor as indicated.
  • Complete FDA 1572 and financial disclosure forms.
  • Attend study initiation meetings with sponsor.
  • Communicate with Institutional Review Board during protocol approval process and subject safety issues.
  • Explain study to subject and answer questions, ensure proper consent, and perform screening examination.
  • Final review of all screening data and authorization of subjects to be enrolled in the study.
  • Perform scheduled per protocol, and unscheduled per adverse event, physicals during study conduct.
  • Manage adverse events/clinical evaluation of subjects and determine adverse event relationship to investigational product, severity, and etiology.
  • Review pre-dose lab work, ECGs, and other study data and determine appropriate action plan based on these results.
  • Review safety data with sponsor.
  • Compose SAE and other reporting documents as indicated.
  • Review and sign Case Report Forms and final Clinical Study Reports.
  • Review all serious adverse events and SUSARs to the Sponsor and IRB within statutory timelines.
  • Data review of all end-of-study data to determine if re-checks are necessary.
  • Safety-monitoring – perform end-of-study physical exams and follow-up ongoing adverse events.
  • Case Report Forms review – review and sign all case report forms at end of study.
  • Assist in on-site client review of case report forms.
  • Assist with identifying and maintaining a network of physician specialists to contract on studies.
  • Present Celerion’s capabilities and experience during sponsor meetings and events.
  • Assist in the design of study and time/event schedules involving special medical procedures.
  • Function as a medical/clinical informational resource for the site.
  • Assist other departments with development of SOPs, training plans, etc.
  • Facilitate emergency response training and review of clinical safety procedures.

Celerion specializes in early phase drug development as a clinical research organization (CRO). The company provides a range of services to pharmaceutical and biotechnology companies, including clinical trial design, feasibility studies, project management, and regulatory affairs. Celerion uses advanced bioanalytical techniques, particularly High Resolution Mass Spectrometry (HR MS), for metabolite profiling and identification, which enhances their research capabilities. This focus on bioanalytical sciences and their extensive experience allows Celerion to assist clients in making informed decisions during the early stages of drug development. Unlike many competitors, Celerion emphasizes speed and quality in their research processes, aiming to help clients bring new treatments to market more quickly, ultimately benefiting patients around the world.

Company Stage

Acquired

Total Funding

N/A

Headquarters

Lincoln, Nebraska

Founded

2010

Growth & Insights
Headcount

6 month growth

11%

1 year growth

11%

2 year growth

13%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased demand for decentralized clinical trials benefits Celerion's global operations.
  • The rise of personalized medicine aligns with Celerion's bioanalytical expertise.
  • Expansion in cell and gene therapy research boosts demand for Celerion's services.

What critics are saying

  • Emerging CROs offering similar services at lower costs threaten Celerion's market share.
  • Regulatory changes in key markets could increase compliance costs for Celerion.
  • The acquisition by H.I.G. Capital may lead to strategic shifts affecting stability.

What makes Celerion unique

  • Celerion specializes in early-phase drug development with over 40 years of experience.
  • The company excels in metabolite profiling using High Resolution Mass Spectrometry (HR MS).
  • Celerion's global capabilities enable comprehensive clinical trial services worldwide.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE